0.1645
price up icon0.43%   0.0007
after-market Dopo l'orario di chiusura: .17 0.0055 +3.34%
loading

In 8 Bio Inc Azioni (INAB) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
125.15%
0.083
-0.33 - - 0.33
Operating Expenses
13.78%
8.645
7.598 7.169 7.715 7.855
Benefits Costs and Expenses
8.645
- 7.169 7.715 7.855
Costs And Expenses
8.645
- 7.169 7.715 7.855
Operating Income/Loss
8.00%
-8.562
-7.928 -7.169 -7.715 -7.525
Income/Loss From Continuing Operations Before Tax
35.81%
-8.562
-13.34 -7.169 -7.715 -7.525
Income/Loss From Continuing Operations After Tax
12.69%
-8.562
-7.598 -7.169 -7.715 -7.525
Net Income/Loss
12.69%
-8.562
-7.598 -7.169 -7.715 -7.525
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
2,623%
43.29
1.5897 31.55 28.47 24.73
Diluted Average Shares
2,623%
43.29
1.5897 31.55 28.47 24.73
Basic Earnings Per Share
4.76%
-0.20
-0.21 -0.23 -0.27 -0.30
Diluted Earnings Per Share
4.76%
-0.20
-0.21 -0.23 -0.27 -0.30
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.60
price up icon 0.88%
$68.28
price up icon 0.60%
$32.75
price up icon 1.99%
$24.29
price up icon 0.37%
$92.80
price down icon 2.05%
biotechnology ONC
$232.25
price down icon 3.93%
Capitalizzazione:     |  Volume (24 ore):